KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 114 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $456,000 | -77.2% | 29,429 | -71.7% | 0.09% | -81.2% |
| Q4 2019 | $1,996,000 | +77.0% | 104,100 | -11.2% | 0.49% | +56.2% |
| Q3 2019 | $1,128,000 | -64.3% | 117,250 | -77.7% | 0.31% | -64.9% |
| Q2 2019 | $3,156,000 | +21.5% | 526,900 | +18.4% | 0.89% | +13.6% |
| Q1 2019 | $2,598,000 | -37.7% | 444,900 | 0.0% | 0.79% | -47.4% |
| Q4 2018 | $4,169,000 | -48.3% | 444,900 | -6.1% | 1.50% | -32.9% |
| Q3 2018 | $8,071,000 | +13.9% | 473,901 | +13.7% | 2.23% | +0.4% |
| Q2 2018 | $7,083,000 | – | 416,900 | – | 2.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 999,275 | $37,403,000 | 55.08% |
| New Leaf Venture Partners, L.L.C. | 126,687 | $4,742,000 | 2.31% |
| Cormorant Asset Management, LP | 385,000 | $14,411,000 | 2.22% |
| SECTORAL ASSET MANAGEMENT INC | 529,920 | $19,835,000 | 0.89% |
| PFM Health Sciences, LP | 850,337 | $31,828,000 | 0.74% |
| Partner Investment Management, L.P. | 16,399 | $614,000 | 0.25% |
| Tekla Capital Management LLC | 137,766 | $5,157,000 | 0.24% |
| Candriam S.C.A. | 298,000 | $11,154,000 | 0.23% |
| Eventide Asset Management | 30,000 | $1,123,000 | 0.12% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 81,047 | $3,034,000 | 0.12% |